Published June 1, 2023 | Version v1
Dataset Open

Serum miRnome Profiling: A Novel Biomarker Platform for the Early Detection of NSCLC

Creators

  • 1. Center of Experimental Medicine, Medical University of Bialystok, 15-369 Bialystok, Poland
  • 2. Department of Clinical Molecular Biology, Medical University of Bialystok, 15-269 Bialystok, Poland
  • 3. 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, 15-540 Bialystok, Poland
  • 4. Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-089 Bialystok, Po-land
  • 5. 1st Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, 15-540 Bialystok, Poland
  • 6. Szentagothai Research Center, Genomic and Bioinformatic Core Facility, H-7624 Pecs, Hungary
  • 7. Turku Bioscience Centre, University of Turku & Åbo Akademi University
  • 8. Department of Thoracic Surgery, Medical University of Bialystok, 15-276 Bialystok, Poland
  • 9. Department of Oncology, Medical University of Warsaw, 02-091 Warsaw, Poland
  • 10. Biobank, Medical University of Bialystok, 15-269 Bialystok, Poland
  • 11. Department of Hematology Diagnostics and Genetics, The University Hospital, 30-688 Krakow
  • 12. Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-089 Bialystok

Description

Table S1: DEmiRNAs between cancerous and non-cancerous patients; Table S2: Shared DE miRNAs between subgroups; Table S3: NSCLC vs control_GO_BP_results; Table S4: NSCLC vs control_GO_CC_results; Table S5: NSCLC vs control_GO_MF_results; Table S6: NSCLC vs control_KEGG_results.

Files

Cells_Supplementary_miRNA serum.pdf

Files (621.6 kB)

Name Size Download all
md5:598a4d827c6155a40a2870a1e5f9bcc2
621.6 kB Preview Download